34 search results for: diagnosis

Factors Contributing to Diagnostic Delays in Bullous Pemphigoid
Dermatology
Factors Contributing to Diagnostic Delays in Bullous Pemphigoid
expert video

Dr. Donna Culton focuses on the challenges of diagnosis and the unmet needs for patients with BP

View more
What We Know About Bullous Pemphigoid (BP): Challenges of the Various Clinical Manifestations, Diagnosis, and Burden for Patients and Caregiver
Dermatology
What We Know About Bullous Pemphigoid (BP): Challenges of the Various Clinical Manifestations, Diagnosis, and Burden for Patients and Caregivers
expert video

In this ADVENT symposium at the 2024 EADV meeting, Professor Joost Meijer highlights the heterogeneous nature of BP and the resultant burden for patients.

View more
Identifying BP: How do symptoms of BP and their severity alter patient <b>diagnosis</b>?
Dermatology
Identifying BP: How do symptoms of BP and their severity alter patient diagnosis?
expert video

Dr. Victoria Werth explains how diagnosing BP can pose many difficulties in patients due to the variation of symptoms and symptom severity. Dr. Werth also discusses what burden and challenges BP patients might expect as a result.

View more
FeNO Is a Noninvasive Biomarker That Can Support <b>Diagnosis</b> and Management for Asthma Patients
Pulmonology
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Infographic

Learn how FeNO, a noninvasive biomarker for type 2 inflammation, can be used to optimize care for asthma patients.

View more
Guideline-Based <b>Diagnosis</b> of Atopic Dermatitis
Dermatology
Guideline-Based Diagnosis of Atopic Dermatitis
interactivity

Explore 3 interactive patient cases to learn more about the signs, symptoms, and burden of atopic dermatitis. Diagnose the patients based on a variety of cases and presentations based on American Academy of Dermatology (AAD) criteria and assess their disease severity

View more
Blisters and Beyond: Autoimmunity Meets Type 2 Inflammation in Bullous Pemphigoid
Dermatology
Blisters and Beyond: Autoimmunity Meets Type 2 Inflammation in Bullous Pemphigoid
expert video

Join Dr. Victoria Werth in exploring the clinical presentation of BP and how type 2 inflammation contributes to the development of disease signs and symptoms

View more
Risk of Mortality and Infections in Bullous Pemphigoid
Dermatology
Risk of Mortality and Infections in Bullous Pemphigoid
expert video

Dr. Victoria Werth walks through the serious comorbidity risks associated with BP diagnosis

View more
<b>Diagnosis</b> of Bullous Pemphigoid Interactive Patient Case
Dermatology
Diagnosis of Bullous Pemphigoid Interactive Patient Case
interactivity

An interactive patient case tool involving a deeper dive into assessing clinical presentation when diagnosing bullous pemphigoid (BP)

View more
IgE as a Biomarker for Type 2 Asthma
Pulmonology
IgE as a Biomarker for Type 2 Asthma
expert video

Dr. Jonathan Corren describes the diagnostic, predictive, and prognostic role of IgE as a biomarker of type 2 inflammation in asthma.

View more
CRSwNP Interactive Patient Case Tool
Rhinology
CRSwNP Interactive Patient Case Tool
interactivity

Meet Fernando. Journey through his clinical profile, applying guideline-based checklists to reach a consensus regarding his diagnosis.

View more
EAPS
Congress
17
October
2024
Congress
ADVENT at EAPS 2024

The ADVENT program will present a symposium to discuss diagnosis, pathophysiology, comorbidities of atopic dermatitis in children, as well as emerging treatment options for management of atopic dermatitis (AD) in children, who are candidates for systemic therapy at the 2024 European Academy of Paediatric Societies (EAPS) Congress.

Bullous Pemphigoid (BP): Exploring New Frontiers
Dermatology
Bullous Pemphigoid (BP): Exploring New Frontiers
expert video

Join experts Dédée Murrell, Donna Aline Culton, Joost Meijer and Enno Schmidt for an educational presentation on the clinical presentation, disease burden, diagnosis, and underlying pathophysiology of bullous pemphigoid (BP). Dive deeper into unmet needs and treatment challenges faced by these patients and how targeted therapies may address them.

View more